[ Price : $8.95]
The HHS Inspector General says FDA should do more to implement 2003 corrective actions called for by the commissioner to improve r...[ Price : $8.95]
A Harris Interactive/Wall Street Journal Online poll finds that 62% of adults would support prohibiting off-label prescription dru...[ Price : $8.95]
FDAs Clinical Chemistry and Clinical Toxicology Devices Panel says lipid subfraction assays may have some value in assessing patie...[ Price : $8.95]
Eli Lilly files an NDA to FDA for Evista seeking approval to use the drug in postmenopausal women to reduce risk of invasive breas...[ Price : $8.95]
The Council for Responsible Nutrition urges the House to quickly approve Senate-backed legislation requiring supplement and OTC dr...[ Price : $8.95]
In our latest analysis of FDA employee compensation, we find the pay of top field leaders increased in 2005, top earners exceeded ...[ Price : $8.95]
FDA wants more information on an adverse event from a Cephalon modafinil trial.[ Price : $8.95]
The U.S. Senate votes 80-11 to confirm Andrew von Eschenbach as FDAs next commissioner, following a successful cloture move by maj...